We provide the new products from Tocris Biosciences, Inc., which were added in October 2010.
You can move to the Tocris’ website to know the detail of the products when you click the catalogue number or Product name on the list.
| Tocris' cat# | Products | Activity | Size | Price | Add to Cart |
|---|---|---|---|---|---|
| 3854 | 1-Oleoyl lysophosphatidic acid sodium salt | Endogenous agonist of the lysophospholipid receptors LPA1 and LPA2. Inhibits differentiation of neural stem cells | 1mg | 9,500 | |
| 2430 | GGTI 298 | Geranylgeranyltransferase I (GGTase I) inhibitor | 1mg | 44,500 | |
| 3516 | Tunicamycin | Antibiotic; GlcNAc phosphotransferase inhibitor | 10mg | 42,500 | |
| 3897 | API-1 | Selective Akt/PKB inhibitor. Antitumor | 10mg | 77,500 | |
| 3989 | AMTB hydrochloride | TRPM8 blocker | 10mg | 49,500 | |
| 50mg | 219,500 | ||||
| 4059 | [Glu27]-PKC (19-36) | Inactive control peptide for PKC (19-36), a pseudosubstrate peptide inhibitor of protein kinase C. | 1mg | 32,500 | |
| 3795 | TUG 424 | Agonist of the free fatty acid receptor FFA1 (GPR40). Sold under license from the University of Southern Denmark(1). | 10mg | 44,500 | |
| 50mg | 192,500 | ||||
| 3998 | LDN 57444 | Ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor | 10mg | 32,500 | |
| 50mg | 139,500 | ||||
| 3360 | CGP 52411 | Selective inhibitor of the epidermal growth factor receptor (EGFR). Also inhibits the formation of Aβ42 fibers associated with Alzheimer's disease. | 10mg | 37,500 | |
| 50mg | 164,500 | ||||
| 2766 | Naspm trihydrochloride | Ca2+-permeable AMPA receptor antagonist | 10mg | 240,000 | |
| 3743 | BF 2649 | H3 receptor inverse agonist/antagonist | 10mg | 37,500 | |
| 50mg | 164,500 | ||||
| 3893 | S 107 hydrochloride | Type 1 ryanodine receptor (RyR1) stabilizer; inhibits Ca2+ leak from the sarcoplasmic reticulum (SR) | 10mg | 42,500 | |
| 50mg | 174,500 | ||||
| 3947 | exo-IWR 1 | Negative control for endo-IWR 1 (Cat.No. 3532) | 10mg | 34,500 | |
| 50mg | 147,500 | ||||
| 4025 | α-Amanitin | Inhibitor of RNA polymerase II | 1mg | 62,500 | |
| 4042 | PSC 833 | P-glycoprotein (P-gp) modulator, Inhibitor of P-gp -mediated multidrug-resistance (MDR) | 1mg | 54,500 | |
| 3829 | UK 78282 hydrochloride | Blocker of KV1.3 and KV1.4 channels in T lymphocytes |
10mg | 52,500 | |
| 50mg | 227,500 | ||||
| 3759 | Exemestane | Irreversible steroidal aromatase (CYP19) inhibitor. Sold for research purposes under agreement from Pfizer Inc(2). | 10mg | 42,500 | |
| 50mg | 174,500 | ||||
| 3761 | Tolterodine L-tartrate | Potent, non-selective muscarinic receptor antagonist. Sold for research purposes under agreement from Pfizer Inc(3). | 10mg | 32,500 | |
| 50mg | 139,500 | ||||
| 2918 | Veratridine | Voltage-gated Na+ channel opener | 10mg | 24,500 | |
| 50mg | 104,500 | ||||
| 3921 | NIDA 41020 | High affinity CB1 antagonist | 10mg | 47,500 | |
| 50mg | 202,500 | ||||
| 3831 | LG 100754 | Novel RXR:PPARγ agonist | 10mg | 57,500 | |
| 50mg | 244,500 |